Toward a Controlled Human Infection Model of Pertussis.
作者信息
Merkel Tod J
机构信息
Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
出版信息
Clin Infect Dis. 2020 Jul 11;71(2):412-414. doi: 10.1093/cid/ciz842.
Abstract
摘要
相似文献
1
Toward a Controlled Human Infection Model of Pertussis.
Clin Infect Dis. 2020 Jul 11;71(2):412-414. doi: 10.1093/cid/ciz842.
2
Two Distinct Episodes Of Whooping Cough Caused By Consecutive Bordetella Pertussis And Bordetella Parapertussis Infections In A Fully Immunized Healthy Boy.
Pediatr Infect Dis J. 2016 Nov;35(11):1275-1276. doi: 10.1097/INF.0000000000001295.
3
The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
Infect Immun. 2007 Oct;75(10):4972-9. doi: 10.1128/IAI.00763-07. Epub 2007 Aug 13.
4
Do Pertussis Vaccines Protect Against Bordetella parapertussis?
Clin Infect Dis. 2017 Jun 15;64(12):1795-1797. doi: 10.1093/cid/cix221.
5
Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Clin Microbiol Infect. 2012 Sep;18(9):E340-6. doi: 10.1111/j.1469-0691.2012.03925.x. Epub 2012 Jun 21.
6
Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
Pathog Dis. 2015 Oct;73(7). doi: 10.1093/femspd/ftv055. Epub 2015 Aug 4.
7
Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Vaccine. 2013 Oct 25;31(45):5262-8. doi: 10.1016/j.vaccine.2013.08.059. Epub 2013 Sep 5.
8
Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
Vaccine. 2010 Jun 17;28(27):4362-8. doi: 10.1016/j.vaccine.2010.04.053. Epub 2010 May 15.
9
A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
Microbiol Immunol. 2017 Oct;61(10):407-415. doi: 10.1111/1348-0421.12532. Epub 2017 Sep 26.
10
Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study.
Diagn Microbiol Infect Dis. 2012 Apr;72(4):303-17. doi: 10.1016/j.diagmicrobio.2012.01.002. Epub 2012 Feb 6.
引用本文的文献
1
Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.
Infect Chemother. 2025 Mar;57(1):13-30. doi: 10.3947/ic.2024.0117.
2
Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas.
Malar J. 2025 Feb 1;24(1):33. doi: 10.1186/s12936-025-05277-x.
3
Controlled Human Infection Models To Accelerate Vaccine Development.
Clin Microbiol Rev. 2022 Sep 21;35(3):e0000821. doi: 10.1128/cmr.00008-21. Epub 2022 Jul 6.
4
The History of Pertussis Toxin.
Toxins (Basel). 2021 Sep 5;13(9):623. doi: 10.3390/toxins13090623.
5
Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.
Front Immunol. 2021 Jun 15;12:701285. doi: 10.3389/fimmu.2021.701285. eCollection 2021.
6
The Path to New Pediatric Vaccines against Pertussis.
Vaccines (Basel). 2021 Mar 5;9(3):228. doi: 10.3390/vaccines9030228.
本文引用的文献
1
Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations.
Vaccine. 2019 Jul 18;37(31):4256-4261. doi: 10.1016/j.vaccine.2019.06.009. Epub 2019 Jun 21.
2
Vaccination Coverage Among Children Aged 19-35 Months - United States, 2017.
MMWR Morb Mortal Wkly Rep. 2018 Oct 12;67(40):1123-1128. doi: 10.15585/mmwr.mm6740a4.
3
Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.
J Clin Invest. 2018 Aug 31;128(9):3853-3865. doi: 10.1172/JCI121309. Epub 2018 Aug 6.
4
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2018 Apr 27;67(2):1-44. doi: 10.15585/mmwr.rr6702a1.
5
The Pertussis resurgence: putting together the pieces of the puzzle.
Trop Dis Travel Med Vaccines. 2016 Dec 12;2:26. doi: 10.1186/s40794-016-0043-8. eCollection 2016.
6
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874-882. doi: 10.15585/mmwr.mm6633a2.
7
Pertussis disease and transmission and host responses: insights from the baboon model of pertussis.
J Infect. 2017 Jun;74 Suppl 1:S114-S119. doi: 10.1016/S0163-4453(17)30201-3.
8
Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.
Vaccine. 2017 Jun 8;35(26):3395-3400. doi: 10.1016/j.vaccine.2017.05.008. Epub 2017 May 12.
9
Pertussis: Microbiology, Disease, Treatment, and Prevention.
Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15.
10
Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.
JAMA Pediatr. 2016 May 1;170(5):453-8. doi: 10.1001/jamapediatrics.2015.4875.
Zotero 插件